B1VAN5 AF NFT

Polyribonucleotide nucleotidyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeib3dg6fcd36izeghefhitc73eu4m3l2oy2cuacneqbccdzkuh7l5u/metadata.json
IPFS of structure file: 
bafybeie4ktrbk33yllclejibuasn3b3avjptxu3w42r7tju34syqtdbdwa/AF-B1VAN5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7Be92d8bdcB542e761fbcA406db9F1e2Df9F8F8C
First NFT owner address (bech32): 
genesis1005jmz7uk4pwwc0mefqxmw03ut0elruv3s3cgy
Current NFT ID #304427 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
304427
Accession (UniProt):
B1VAN5
Name::
Polyribonucleotide nucleotidyltransferase
Experimental Method:
Predicted structure
Sequence source:
Phytoplasma australiense

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B1VAN5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B1VAN5|PNP_PHYAS Polyribonucleotide nucleotidyltransferase OS=Phytoplasma australiense OX=59748 GN=pnp PE=3 SV=1 MLKQVFETTDLKNSFQVEIGTYARNVDPSVLIRFQDTVVLTTTVFSNKKNNFDFLPLTVIYQEKFYAAGKIPGSFLRREGRSTDHEILSSRLIDRSLRPLFPKEFRQEIQVINTVLSSNPDFKSEIASILGSSLSLLISEIPFFEPVAGVYVAYIQNQFVINPNAQQLTNSPLHLLVAGTKKNVVMIEAHASEVSEEMFLEAIVFAHEYIKKLCLFQEDVQKKVGQTKKLIDLDAELQSLEKEFNEQYHEQTRTLVANVFEQDQKNDLQVFKKKILAKAQQKAFVKTIDQITFFDVEEQKNYLLLIENLFQKLFNQEMRNYIIKNKKRPDKRTLEEVRNLDSQIDLLPRPHGSALFTRGQTQSLAVVTLGTLSESKIIDDLSGESNKRFMLHYNFPPFAVGSIGRYAAPSRREIGHGNLAEKAILPLLPEENDFPYAIRVVSEILESNGSSSQATVCATSMSLMAAGVPLKRAVSGIAMGLFMDSKTNEYVILSDIQGLEDHIGDMDLKIAGSDKGITALQMDLKIEGISQAILKQAFFQAKKGRLHILEHMNKTIASPRKEMSQYAPKVQMFQIKPEKIRDVIGSAGKIINQIIENHDGVKIDIEQDGRIFVMHSNLETVKQAILFIKNLIQDAEVNSIYHAHISRFLNDKAGNILGAFAQVSPSIEGLIRFSKAKKENDVVKIGDKVLVKCVKINERGRIDFVLISKK